Di-(2-ethylhexyl) adipate


Literature identifierStudy typeTest dosageEffective dosageEndocrine-mediated endpointsSystems-level perturbations
PMID:1154415IVR10 mL/kg 10 mL/kgAffects implantationReproductive endocrine-mediated perturbations
IVR10 mL/kg 10 mL/kgAffects fertilityReproductive endocrine-mediated perturbations
IVR0.5 mL/kg 0.5 mL/kgAffects fertilityReproductive endocrine-mediated perturbations
IVR0.5 mL/kg 0.5 mL/kgAffects implantationReproductive endocrine-mediated perturbations
IVR5 mL/kg 5 mL/kgAffects fertilityReproductive endocrine-mediated perturbations
IVR5 mL/kg 5 mL/kgAffects implantationReproductive endocrine-mediated perturbations
IVR1 mL/kg 1 mL/kgAffects implantationReproductive endocrine-mediated perturbations
IVR1 mL/kg 1 mL/kgAffects fertilityReproductive endocrine-mediated perturbations
PMID:16493179IVR480 mg/L 480 mg/LAffects social behaviorNeurological endocrine-mediated perturbations
IVR480 mg/L 480 mg/LAffects embryonic developmentDevelopmental endocrine-mediated perturbations
IVR480 mg/L 480 mg/LAffects sexual behaviorNeurological endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations
IVR480 mg/L 480 mg/LAltered lordosisDevelopmental endocrine-mediated perturbations
IVR12000 mg/L 12000 mg/LAffects embryonic developmentDevelopmental endocrine-mediated perturbations
IVR12000 mg/L 12000 mg/LAffects anogenital distance in offspringDevelopmental endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations
IVR12000 mg/L 12000 mg/LAltered lordosisDevelopmental endocrine-mediated perturbations
IVR2400 mg/L 2400 mg/LAffects sexual behaviorNeurological endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations
IVR2400 mg/L 2400 mg/LAffects anogenital distance in offspringDevelopmental endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations
IVR2400 mg/L 2400 mg/LAltered lordosisDevelopmental endocrine-mediated perturbations

DISCLAIMER

We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.